Ocugen, Inc

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.

About OCGN

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN.

CEO

Shankar Musunuri

CEOShankar Musunuri

Employees

Employees95

Headquarters

Malvern, Pennsylvania

HeadquartersMalvern, Pennsylvania

Founded

2013

Founded2013

Employees

Employees95

OCGN Key Statistics

Market cap

294.95M

Market cap294.95M

Price-Earnings ratio

-5.46

Price-Earnings ratio-5.46

Dividend yield

—

Dividend yield—

Average volume

4.33M

Average volume4.33M

High today

$1.06

High today$1.06

Low today

$1.00

Low today$1.00

Open price

$1.03

Open price$1.03

Volume

2.36M

Volume2.36M

52 Week high

$1.77

52 Week high$1.77

52 Week low

$0.515

52 Week low$0.515

OCGN News

TipRanks 3d

Ocugen announces first patient dosed in Phase 2/3 GARDian3 trial for OCU410ST

Ocugen (OCGN) announced that the first patient has been dosed in its Phase 2/3 GARDian3 clinical trial for OCU410ST-a modifier gene therapy candidate being deve...

People also own

Based on the portfolios of people who own OCGN. This list is generated using Robinhood data, and it’s not a recommendation.